An Open-label, Randomized Phase 3 Study of MK-6482 Versus Everolimus in Participants with Advanced Renal Cell Carcinoma That Has Progressed After Prior PD-1/L1 and VEGF-Targeted Therapies
NOT ENROLLING
Trial ID:
NCT04195750 Protocol # :
19-897
Phase
III
Disease Sites
Kidney
Principal Investigator
Choueiri, Toni, K
Site Investigator
Gao, Xin
McDermott, David, F.
Site Research Nurses
Bretta, Katherine, v.
Cash, Hanna, Marie
Childs, Alexandra
Gotthardt, Susan, Jean
Gurski, Carol
Healy, Erin, C.
Jundzil, Theresa
Kabarame, Liliane
Kelleher, Kaitlin
Lagerstedt, Elizabeth
Leisner, Claire
Markt, Denise, A.
Mingrino, Sage
Pace, Amanda
Porter, Kathryn
Prisby, Judith
Sweet, Amanda
Theodore, Catherine
Walsh, Meghara
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #19-897
19-897